GlassScriptPhysician profile
Tiffany A Parker
NPI 1497937197
$6,416.66
in general payments reported to CMS, 2019-2025
22 companies · $1,316 in 2025
The $1,316 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $832 · 2022: $1,266 · 2023: $1,705 · 2024: $1,298 · 2025: $1,316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,910 · Education: $409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,910.10 |
| Education | $408.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,464.41 | 2021-2025 | Tremfya, Stelara, Simponi |
| Abbvie INC. | $1,280.92 | 2021-2025 | |
| Pfizer INC. | $799.77 | 2021-2025 | |
| Lilly USA, LLC | $687.31 | 2021-2025 | Taltz, Ebglyss, Olumiant |
| Genzyme Corporation | $657.05 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $559.95 | 2021-2025 | |
| Incyte Corporation | $217.25 | 2021-2025 | Opzelura |
| Leo Pharma INC. | $148.81 | 2021-2023 | Adbry |
| Ucb, INC. | $129.46 | 2021-2025 | Bimzelx |
| Arcutis Biotherapeutics, INC. | $113.97 | 2023-2025 | Zoryve |
| E.R. Squibb & Sons, L.L.C. | $76.64 | 2022-2023 | Sotyktu |
| Amgen INC. | $66.49 | 2021-2025 | Otezla |
| Convatec INC. | $48.18 | 2024 | |
| Organon LLC | $27.83 | 2025 | Vtama |
| Paratek Pharmaceuticals, INC. | $24.60 | 2024 | Nuzyra |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $22.80 | 2021 | |
| Dermavant Sciences, INC. | $19.56 | 2024 | Vtama |
| Biofrontera INC. | $16.97 | 2025 | |
| Sandoz INC. | $16.83 | 2023 | Hyrimoz |
| Biowound Solutions, INC. | $13.21 | 2025 | Bio-Connekt |
| Sun Pharmaceutical Industries INC. | $12.82 | 2021 | |
| Galderma Laboratories, L.P. | $11.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Parker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.